Entity Common Stock, Shares Outstanding of Apollo Endosurgery, Inc. from 05 Aug 2011 to 15 Mar 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Apollo Endosurgery, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 05 Aug 2011 to 15 Mar 2023.
  • Apollo Endosurgery, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 15 Mar 2023 was 57,971,919, a 44% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Apollo Endosurgery, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 57,971,919 +17,721,517 +44% 15 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 41,634,162 +2,141,636 +5.4% 28 Oct 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 40,686,452 +11,983,484 +42% 29 Jul 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 40,250,402 +13,214,560 +49% 29 Apr 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 39,623,333 +13,639,486 +52% 31 Jan 2022 10-K 22 Feb 2022 2021 FY
Q3 2021 39,492,526 +13,708,972 +53% 29 Oct 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 28,702,968 +5,026,581 +21% 30 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 27,035,842 +5,907,741 +28% 30 Apr 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 25,983,847 31 Jan 2021 10-K 25 Feb 2021 2020 FY
Q3 2020 25,783,554 +4,839,270 +23% 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 23,676,387 +1,743,279 +7.9% 31 Jul 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 21,128,101 -794,243 -3.6% 24 Apr 2020 10-Q 04 May 2020 2020 Q1
Q3 2019 20,944,284 -949,225 -4.3% 25 Oct 2019 10-Q 30 Oct 2019 2019 Q3
Q2 2019 21,933,108 +54,212 +0.25% 19 Jul 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 21,922,344 +4,412,895 +25% 30 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 21,893,509 +4,603,162 +27% 31 Oct 2018 10-Q/A 13 Nov 2018 2018 Q3
Q2 2018 21,878,896 +4,626,597 +27% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 17,509,449 +6,810,352 +64% 30 Apr 2018 10-Q 03 May 2018 2018 Q1
Q3 2017 17,290,347 +14,886,161 +619% 20 Oct 2017 10-Q 26 Oct 2017 2017 Q3
Q2 2017 17,252,299 +14,878,274 +627% 26 Jul 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 10,699,097 -22,405,967 -68% 30 Apr 2017 10-Q 04 May 2017 2017 Q1
Q3 2016 2,404,186 -30,002,485 -93% 07 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 2,374,025 -27,028,677 -92% 08 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 33,105,064 +13,783,808 +71% 08 May 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 33,138,598 12 Feb 2016 10-K 22 Mar 2016 2015 FY
Q3 2015 32,406,671 +13,129,071 +68% 11 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 29,402,702 +13,784,036 +88% 07 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 19,321,256 +4,343,161 +29% 11 Mar 2015 10-K 24 Mar 2015 2014 FY
Q3 2014 19,277,600 +6,095,686 +46% 11 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 15,618,666 +2,472,040 +19% 08 Aug 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 14,978,095 +1,849,845 +14% 14 Mar 2014 10-K 18 Mar 2014 2013 FY
Q3 2013 13,181,914 +2,594,663 +25% 07 Nov 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 13,146,626 -60,590,364 -82% 09 Aug 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 13,128,250 -60,592,698 -82% 15 Mar 2013 10-K 15 Mar 2013 2012 FY
Q3 2012 10,587,251 -49,953,891 -83% 06 Nov 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 73,736,990 +13,218,348 +22% 09 Aug 2012 10-Q 13 Aug 2012 2012 Q2
Q1 2012 73,720,948 15 Mar 2012 10-K 16 Mar 2012 2011 FY
Q3 2011 60,541,142 31 Oct 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 60,518,642 05 Aug 2011 10-Q 12 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.